<DOC>
	<DOC>NCT02094963</DOC>
	<brief_summary>The purpose of this study is to assess safety and efficacy of Ticagrelor versus Clopidogrel in Asian/KOREAn patients with acute coronary syndromes intended for invasive management.</brief_summary>
	<brief_title>Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients With Acute Coronary Syndromes Intended for Invasive Management</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>Age 18 and more Index event of nonST or ST segment elevation ACS Provision of signed informed consent Hypersensitivity to aspirin or ticagrelor Oral anticoagulation therapy that cannot be stopped Treated with thrombolysis within 24hrs Any other reason the investigator deems the subject to be unsuitable for the study e.g., Active malignant tumor Concomitant therapy with strong CYP3A inhibitors, CYP3A substrates with narrow therapeutic index, or strong CYP3A inducers Any lifethreatening condition with life expectancy less than 6months Mental condition (dementia, alcohol or drug abuse) which may be affect study compliance or prevent understanding of the aims, investigational procedures or possible consequences of the study High risk due to malignant hypertension The conditions associated with increased risk of bradycardiac events Subjects with severe liver disease Subjects requiring dialysis Increased bleeding risk History of cerebral hemorrhage, gastrointestinal bleeding within 6months, major surgical procedure within 30days Thrombocytopenia or leukopenia Positive pregnancy test or is known to be pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>acute coronary syndrome</keyword>
	<keyword>coronary disease</keyword>
	<keyword>coronary artery disease</keyword>
</DOC>